Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EPIC SFA - Physician Initiated Trial Investigating the Efficacy of the EPICTM Nitinol Vascular Stent System (Boston Scientific) in Superficial Femoral Lesions: A Prospective, Multi-center Non- Randomized Study - Endoconsul 003

NCT01327950 is registered in ClinicalTrials.gov with Endovascular Consultoria Limitada as lead sponsor.

NCT NCT01327950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01327950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EPIC SFA - Physician Initiated Trial Investigating the Efficacy of the EPICTM Nitinol Vascular Stent System (Boston Scientific) in Superficial Femoral Lesions: A Prospective, Multi-center Non- Randomized Study - Endoconsul 003
Lead sponsor
Endovascular Consultoria Limitada
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
November 30, 2013
Enrollment
86 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis of femoral artery, superficial femoral artery stenosis